2006
DOI: 10.1097/01.ccm.0000220763.85974.e8
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines*

Abstract: We observed a high rate of tolerability among patients with intracerebral hemorrhage who were treated with intravenous nicardipine using mean arterial pressure goals defined by American Heart Association guidelines within 24 hrs of symptom onset.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
37
1

Year Published

2008
2008
2010
2010

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 71 publications
(41 citation statements)
references
References 33 publications
(38 reference statements)
3
37
1
Order By: Relevance
“…SBP is one independent predictor of early neurological deterioration and may be related to an increase in the risk of HE in acute ICH [25, 26]. Therefore, it may be interesting and feasible to study the management of blood pressure in acute ICH patients with sustained very high blood pressure during early assessment [27]. …”
Section: Discussionmentioning
confidence: 99%
“…SBP is one independent predictor of early neurological deterioration and may be related to an increase in the risk of HE in acute ICH [25, 26]. Therefore, it may be interesting and feasible to study the management of blood pressure in acute ICH patients with sustained very high blood pressure during early assessment [27]. …”
Section: Discussionmentioning
confidence: 99%
“…Patients treated within 6 hours of symptom onset were more likely to be functionally independent at 1 month than patients who were treated between 6 and 24 hours. Another study 83 evaluated the tolerability and safety of intravenous nicardipine infusion within 24 hours of symptom onset to reduce and maintain MAP Ͻ130 mm Hg, consistent with previous ASA guidelines. The primary outcome of tolerability was achieved in 86% of the patients.…”
Section: Patients With Ichmentioning
confidence: 99%
“…Indirect comparisons suggest that intermittent intravenous bolus regimens of antihypertensive agents have greater variability in BP control than continous infusion regimens. 83 The current ASA 44 and European Stroke Initiative 45 guidelines recommend lowering BP in patients with an ICH to maintain systolic BP below 180 mm Hg. Both guidelines acknowledge that there may be a subset of patients who can tolerate more aggressive BP reduction, such as those with good neurological status or those without chronic hypertension.…”
Section: Patients With Ichmentioning
confidence: 99%
See 1 more Smart Citation
“…9) Nicardipine, a calcium-channel blocker and potent vasodilator, is usually used to achieve effective reduction in blood pressure, 8,18) and administration is possible and safe in patients with ICH. 25) Therefore, in our institute, patients with ICH are treated with rapid reduction of SBP using nicardipine.…”
Section: Introductionmentioning
confidence: 99%